DOI QR코드

DOI QR Code

Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma

  • Lee, Sung-Eun (Division of Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Yoon, Jae-Ho (Division of Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Shin, Seung-Hwan (Division of Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Park, Gyeongsin (Department of Pathology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Min, Chang-Ki (Division of Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine)
  • Received : 2013.05.16
  • Accepted : 2013.06.11
  • Published : 2013.06.30

Abstract

Graft-versus-host disease (GVHD) is a common complication of allogeneic stem cell transplantation (allo-SCT). However, a similar syndrome has been reported in autologous stem cell transplantation (ASCT) as well. The target organs of GVHD in ASCT are the skin, liver and gastrointestinal (GI) tract, which are consistent with those in allo-SCT. Histologic findings from the skin and the mucosa of the GI tract also show similar features. Here we describe a case of autologous GVHD involving the skin of a patient who underwent ASCT for multiple myeloma. In this patient, the response to a total prednisone dose of 0.5 mg/kg/day was unsatisfactory, and the patient required more intensive and prolonged immunosuppressive therapy with slow tapering.

Keywords

References

  1. Kline, J., S. Subbiah, H. M. Lazarus, and K. van Besien. 2008. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance. Bone Marrow Transplant. 41: 505-513. https://doi.org/10.1038/sj.bmt.1705931
  2. Fidler, C., T. Klumpp, K. Mangan, M. Martin, M. Sharma, R. Emmons, M. Lu, and P. Kropf. 2012. Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant. Am. J. Hematol. 87: 219-221. https://doi.org/10.1002/ajh.22227
  3. Drobyski, W. R., P. Hari, C. Keever-Taylor, R. Komorowski, and W. Grossman. 2009. Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma. Bone Marrow Transplant. 43: 169-177. https://doi.org/10.1038/bmt.2008.295
  4. Goddard, D. S., B. S. Ruben, E. D. Mathes, M. Nixon, J. Wolf, and L. P. Fox. 2010. A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status- post-second auto-SCT. Bone Marrow Transplant. 45: 409-411. https://doi.org/10.1038/bmt.2009.157
  5. Krishna, S. G., B. Barlogie, L. W. Lamps, K. Krishna, F. Aduli, and E. Anaissie. 2010. Recurrent spontaneous gastrointestinal graft-versus-host disease in autologous hematopoietic stem cell transplantation. Clin. Lymphoma Myeloma Leuk. 10: E17-21. https://doi.org/10.3816/CLML.2010.n.012
  6. Baron, F., A. Gothot, J. P. Salmon, J. P. Hermanne, G. E. Pierard, G. Fillet, and Y. Beguin. 2000. Clinical course and predictive factors for cyclosporin-induced autologous graftversus- host disease after autologous haematopoietic stem cell transplantation. Br. J. Haematol. 111: 745-753.
  7. Jones, R. J., G. B. Vogelsang, A. D. Hess, E. R. Farmer, R. B. Mann, R. B. Geller, S. Piantadosi, and G. W. Santos. 1989. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1: 754-757.
  8. Hood, A. F., G. B. Vogelsang, L. P. Black, E. R. Farmer, and G. W. Santos. 1987. Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation. Arch. Dermatol. 123: 745-750. https://doi.org/10.1001/archderm.1987.01660300067014
  9. Holmberg, L., K. Kikuchi, T. A. Gooley, K. M. Adams, D. M. Hockenbery, M. E. Flowers, H. G. Schoch, W. Bensinger, and G. B. McDonald. 2006. Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome. Biol. Blood Marrow Transplant. 12: 226-234. https://doi.org/10.1016/j.bbmt.2005.10.011
  10. Saunders, M. D., H. M. Shulman, C. S. Murakami, T. R. Chauncey, W. I. Bensinger, and G. B. McDonald. 2000. Bile duct apoptosis and cholestasis resembling acute graft-versus- host disease after autologous hematopoietic cell transplantation. Am. J. Surg. Pathol. 24: 1004-1008. https://doi.org/10.1097/00000478-200007000-00012
  11. Cogbill, C. H., W. R. Drobyski, and R. A. Komorowski. 2011. Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases. Mod. Pathol. 24: 117-125. https://doi.org/10.1038/modpathol.2010.163
  12. Nellen, R. G., A. M. van Marion, J. Frank, P. Poblete- Gutierrez, and P. M. Steijlen. 2008. Eruption of lymphocyte recovery or autologous graft-versus-host disease? Int. J. Dermatol. 47 Suppl 1: 32-34. https://doi.org/10.1111/j.1365-4632.2008.03956.x
  13. Lazarus, H. M., S. R. Sommers, L. M. Arfons, P. Fu, S. A. Ataergin, N. M. Kaye, F. Liu, T. L. Kindwall-Keller, B. W. Cooper, M. J. Laughlin, R. J. Creger, P. M. Barr, S. L. Gerson, and D. Kaplan. 2011. Spontaneous autologous graft-versus- host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts. Biol. Blood Marrow Transplant. 17: 970-978. https://doi.org/10.1016/j.bbmt.2011.03.005

Cited by

  1. Kutane Graft-versus-Host-Erkrankung vol.69, pp.2, 2013, https://doi.org/10.1007/s00105-017-4112-3
  2. Gene Therapy for Cerebral Adrenoleukodystrophy vol.378, pp.5, 2013, https://doi.org/10.1056/nejmc1715427
  3. Are graft-versus-host-disease patients missing out on the vital occupational therapy services? a systematic review vol.41, pp.2, 2013, https://doi.org/10.1097/mrr.0000000000000275
  4. Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation vol.23, pp.1, 2013, https://doi.org/10.5114/wo.2019.83815
  5. Cutaneous manifestations of acute and chronic graft-versus-host disease vol.155, pp.1, 2013, https://doi.org/10.23736/s0392-0488.19.06535-0
  6. Graft-versus-host disease as an unusual complication following autologous stem cell transplantation vol.51, pp.1, 2013, https://doi.org/10.2478/ahp-2020-0010
  7. Graft-versus-host disease as an unusual complication following autologous stem cell transplantation vol.51, pp.1, 2013, https://doi.org/10.2478/ahp-2020-0010